Pressreleases

Magnus Henell has formally taken office as acting CEO in I-Tech

I-Tech AB (“I-Tech” or the “Company”) announces that Magnus Henell today has taken office as acting CEO after Philip Chaabane. The recruitment of a new ordinary CEO is ongoing.

As communicated by the Company in a press release on 15th January 2024, the Company and Philip Chaabane has agreed that Philip Chaabane shall step down as the Company’s CEO in connection with the Annual General Meeting on 16th May 2024, at which he is proposed as new chairman of the Board of Directors. Before the Annual General Meeting the Company today announces that Philip Chaabane formally has steeped down as CEO and been replace by the Company’s former CFO, Magnus Henell, in accordance with previous communication. The recruitment of a new ordinary CEO is ongoing.

Contacts
Magnus Henell, Acting CEO (CFO and Director Operations)
M: +4673-910 37 03
E: magnus.henell@i-tech.se

About I-Tech AB
I-Tech is a biotechnology company that has developed the product Selektope®, an active agent that prevents barnacle attachment on submerged surfaces such as ships and boat hulls, but also other marine installations. By increasing the resistance to barnacle growth in marine paint systems (e.g. antifouling coatings), fuel and maintenance costs are reduced. I-Tech has obtained the necessary regulatory approvals for Selektope® and has several of the world's largest manufacturers of marine antifouling coatings as customers. The company's share is listed for trading on Nasdaq First North Growth Market in Stockholm. The Company’s Certified Adviser is Carnegie Investment Bank AB (publ). For more information visit our website www.i-tech.se.

Attachments
Magnus Henell has formally taken office as acting CEO in I-Tech

Magnus Henell has formally taken office as acting CEO in I-Tech
Back